Through the proposed partnership, Africa CDC and Aspen plan to establish a multi-year collaboration to boost local manufacturing capacity, improve supply security, and create sustainable markets for African-made vaccines.
The sale came about following an unsolicited offer from BGH Capital, which focuses on investments in Australia and New Zealand.